1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Metagenomics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Metagenomics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Metagenomics Market Regional Analysis
6.2 North America Metagenomics Market Revenue 2016-2027 (US$ Million)
6.3 North America Metagenomics Market Forecast Analysis
7. North America Metagenomics Market Analysis – by Product
7.1 Instruments & Software and Consumables
- 7.1.1 Overview
- 7.1.2 Instruments & Software and Consumables: North America Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
8. North America Metagenomics Market Analysis – by Application
8.1 Clinical Diagnostics
- 8.1.1 Overview
- 8.1.2 Clinical Diagnostics: North America Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
8.2 Drug Discovery Metagenomics
- 8.2.1 Overview
- 8.2.2 Drug Discovery Metagenomics: North America Metagenomics Market – Revenue and Forecast, 2016-2027 (US$ Million)
9. North America Metagenomics Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Metagenomics Market Breakdown, by Key
Country, 2019 and 2027 (%)
- 9.2.1.1 North America Metagenomics Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 US: North America Metagenomics Market Breakdown, by Product
- 9.2.1.1.2 US: North America Metagenomics Market Breakdown, by Application
- 9.2.1.2 Canada:
North America Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Canada: North America Metagenomics Market Breakdown, by Product
- 9.2.1.2.2 Canada: North America Metagenomics Market Breakdown, by Application
- 9.2.1.3 Mexico :
North America Metagenomics Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Mexico : North America Metagenomics Market Breakdown, by Product
- 9.2.1.3.2 Mexico : North America Metagenomics Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Agilent Technologies
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Qiagen
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Bio-Rad Laboratories, Inc.
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Perkinelmer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Illumina Inc.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 F Hoffman-La Roche Ltd.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Oxford Nanopore Technologies Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Pacific Bioscience of California, Inc.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Metagenomics Market
